Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Jiang Chang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8551-9458; OpenAlex author ID A5006101921. Sources: OpenAlex.

Their work

Papers
15 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
39
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: 2 papers · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper

Papers 15

  1. Author Correction: Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Co-author DOI 10.1038/s41467-025-58613-9↗
  2. Systematic analysis on expression quantitative trait loci identifies a novel regulatory variant in ring finger and WD repeat domain 3 associated with prognosis… Co-author DOI 10.1097/cm9.0000000000002180↗
  3. Aberrant RNA Splicing Is a Primary Link between Genetic Variation and Pancreatic Cancer Risk. Co-author DOI 10.1158/0008-5472.can-21-4367↗
  4. Identification of genetic variants in m6A modification genes associated with pancreatic cancer risk in the Chinese population. Last author DOI 10.1007/s00204-021-02978-5↗
  5. A genetic variant conferred high expression of CAV2 promotes pancreatic cancer progression and associates with poor prognosis. Co-author DOI 10.1016/j.ejca.2021.04.008↗
  6. Evaluation of polymorphisms in microRNA-binding sites and pancreatic cancer risk in Chinese population. Co-author DOI 10.1111/jcmm.14906↗
  7. N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression. Co-author DOI 10.1136/gutjnl-2019-320179↗
  8. A genetic variant in PIK3R1 is associated with pancreatic cancer survival in the Chinese population. Last author DOI 10.1002/cam4.2228↗
  9. A functional variant rs1537373 in 9p21.3 region is associated with pancreatic cancer risk. Co-author DOI 10.1002/mc.22968↗
  10. A functional variant in the boundary of a topological association domain is associated with pancreatic cancer risk. Co-author DOI 10.1002/mc.23077↗
  11. Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations. Co-author DOI 10.1038/s41467-018-06136-x↗
  12. BRCA1 missense polymorphisms are associated with poor prognosis of pancreatic cancer patients in a Chinese population. Co-author DOI 10.18632/oncotarget.16422↗
  13. Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation. Co-author DOI 10.1038/ng.3568↗
  14. A single nucleotide polymorphism in the 3'-UTR of STAT3 regulates its expression and reduces risk of pancreatic cancer in a Chinese population. Co-author DOI 10.18632/oncotarget.11607↗
  15. Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Co-author DOI 10.1038/ng.1020↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jianbo Tian · 13 shared papers, 2016–2025 · strength 1.22
  2. Xiaoping Miao · 14 shared papers, 2011–2025 · strength 1.20
  3. Rong Zhong · 12 shared papers, 2016–2025 · strength 1.12
  4. Ying Zhu · 11 shared papers, 2016–2025 · strength 0.99
  5. Pingting Ying · 8 shared papers, 2019–2022 · strength 0.79
  6. Juntao Ke · 8 shared papers, 2016–2025 · strength 0.67
  7. Ming Zhang · 4 shared papers, 2019–2022 · strength 0.40
  8. Chen Hsuan Wu · 4 shared papers, 2011–2025 · strength 0.30
  9. Dongxin Lin · 4 shared papers, 2011–2025 · strength 0.30
  10. Kun Huang · 3 shared papers, 2017–2025 · strength 0.30
  11. Beibei Zhu · 3 shared papers, 2016–2025 · strength 0.29
  12. Shufang Mei · 3 shared papers, 2019–2020 · strength 0.24
  13. Ming Yang · 2 shared papers, 2018–2025 · strength 0.24
  14. Li Wang · 2 shared papers, 2018–2025 · strength 0.24
  15. Ying Zhu · 2 shared papers, 2022 · strength 0.24
  16. Bin Li · 2 shared papers, 2019–2021 · strength 0.17
  17. Zhiyong Yang · 1 shared paper, 2022 · strength 0.11
  18. Min Wang · 1 shared paper, 2022 · strength 0.11
  19. Beibei Zhu · 1 shared paper, 2019 · strength 0.08
  20. Xiaoping Miao · 1 shared paper, 2019 · strength 0.08
  21. Chaohui Zuo · 2 shared papers, 2011–2016 · strength 0.06
  22. Xu Che · 2 shared papers, 2011–2016 · strength 0.06
  23. Dianke Yu · 2 shared papers, 2011–2016 · strength 0.06
  24. Guoliang Jiang · 2 shared papers, 2011–2016 · strength 0.06
  25. Chengfeng Wang · 2 shared papers, 2011–2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.